English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Acute coronary syndrome (ACS) includes unstable angina, non-ST segment elevation myocardial infarction, and ST segment elevation myocardial infarction. Joint guidelines by American College of Cardiology (ACC) and American Heart Association (AHA) in 2007 suggest secondary drug prevention measures to be used in patients with ACS with aspirin, clopidogrel/prasugrel, ACE inhibitors/ ARBs, Statins, Beta blockers. This study is aimed to find out impact of drug use in quality of life of ACS patients during follow up period. Materials and methods: It was a prospective unicentric study done at the OPD of cardiology,R.G.Kar Medical college, Kolkata. All prescriptions issued to study subjects attending the cardiology clinic during 18 months period were intercepted after consultation. Pattern of drug use was noted. Patients were asked 21 questions of “Minnesota living with heart disease questionnaire” and scores were calculated in 3 visits of each patient. Impact of drug use was calculated. Results: 525 patients were included in study. aspirin was given in 100%, clopidogrel/prasugrel in 98.29%, ACEI/ARB in 87.43%, statins in 100%, beta blockers in 86.86%. Total 408 patients were given drugs from all 5 groups. There was overall significant satisfactory improvement with drug therapy. Prescription of all 5 drug groups had significant better outcome in quality of life score than prescription of less than 5 drug groups. Conclusion: Drugs from all these 5 groups should be given to all follow up patients of ACS, unless contraindicated as they significantly improve quality of life of the patients. *- ACE- angiotensin converting enzyme, ARB- angiotensin receptor blocker.

IMPACT OF DRUG USE ON QUALITY OF LIFE IN FOLLOW UP PATIENTS OF ACUTE CORONARY SYNDROME IN A TERTIARY CARE TEACHING HOSPITAL IN EASTERN INDIA